Pygeum (Pygeum africanum)

Nomenclature & Taxonomic Classification

• Botanical Binomial: Pygeum africanum Hook. f. (Synonym: Prunus africana)
• Family: Rosaceae
• Common Name(s): Pygeum, African Plum Tree, Iron Wood
• Parts Used: Bark.

Botanical Description, Habitat & Sustainability

• Physical Description: * Growth Habit: Large evergreen canopy tree growing up to 30–40 meters tall.
  • Morphology: Alternate, oblong, coriaceous (leathery) dark green leaves with a distinct almond scent when crushed. Small white or cream flowers give way to spherical red/black fruits. The dark brown bark is thick and rough.
• Habitat & Cultivation: Native to montane regions of sub-Saharan Africa and Madagascar.
• Sustainability Status: CRITICALLY ENDANGERED / CITES APPENDIX II LISTED. Wild populations have been severely depleted by destructive bark-stripping practices. Only source pygeum certified as sustainably farmed/harvested under strict conservation management.

Energetics & Traditional Actions

• Western Tissue States: Corrects Irritation/Inflammation and Torpor/Stagnation in the lower pelvic basin.
• Traditional Vector:
  • Ayurveda: N/A (Traditional African lineage; functionally acts to reduce excess Kapha and Pitta in the urinary system).
  • Traditional Chinese Medicine: Temperature: Cool | Taste: Bitter, Astringent | Organ Meridians Entered: Kidney, Bladder, Liver.
• Historical Folk Use: Traditional African tribes utilized bark decoctions for centuries to treat “old man’s disease” (urinary difficulties), bladder inflammation, and systemic fevers.

Phytochemistry & Pharmacological Dynamics

• Primary Phytochemicals: Phytosterols (beta-sitosterol), triterpenes (ursolic, oleanolic acids), and ferulic acid esters (docosanol).
• Mechanism of Action: > Pygeum extracts exert multi-targeted pathways: 1) Antagonizes fibroblast growth factors (bFGF), directly inhibiting prostatic fibroblast proliferation. 2) Down-regulates 5-alpha-reductase. 3) Inhibits 5-lipoxygenase (5-LOX), suppressing the production of inflammatory leukotrienes in the prostate gland. 4) Restores secretory function of prostatic epithelium.

Clinical Applications & Indications

• Primary Indications: Benign Prostatic Hyperplasia (BPH) Stages I and II, characterized by nocturia, frequent urination, weak stream, and elevated post-void residual volume.
• Secondary Indications: Prostatitis, chronic pelvic pain syndrome (CPPS), and post-prostatectomy recovery support.
• Modern Clinical Evidence: Extensive Cochrane systematic reviews confirm that standardized pygeum bark extract significantly improves urinary symptoms, reduces nocturia by over 30%, and increases peak urine flow rates compared to placebo.

Preparation, Dosing & Extraction Matrix

• Optimal Menstruum & Extraction Guidelines: Lipophilic components are poorly water-soluble. Standardized lipophilic extracts (usually standardized to 14% triterpenes and 0.5% phytosterols) dissolved in carrier oils or encapsulated are mandatory for clinical outcomes.

Standard Dosage Parameters

Safety Profile, Contraindications & Drug Interactions

• Contraindications: None known when used appropriately. (Not indicated for use in women or children).
• Side Effects & Toxicity Thresholds: Generally very safe. Occasional mild gastrointestinal side effects (nausea, minor gastric pain) may occur if taken on an empty stomach.
• Pharmaceutical Cross-Interactions: * Enzyme Alterations: Non-significant.
  • Additive Pathways: Synergizes positively with Saw Palmetto (Serenoa repens) and may potentiate prescription 5-alpha-reductase inhibitors (Finasteride) and alpha-blockers (Tamsulosin).

References

1. Iwu, M. M. Handbook of African Medicinal Plants.
2. Mills, S., & Bone, K. Essential Guide to Herbal Safety.
3. Wilt, T., et al. (2002). “Pygeum africanum for benign prostatic hyperplasia.” Cochrane Database of Systematic Reviews.